Cencora Inc (COR) Gross Profit Margin starting from the second quarter 2026 to second quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Cencora Inc   (NYSE: COR)


Cencora Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

COR Gross Profit Margin (Mar 31 2026)
Q2 		(Dec 31 2025)
Q1 		(Sep 30 2025)
Q4 		(Jun 30 2025)
Q3 		(Mar 31 2025)
Q2
Y / Y Revenue Change 3.85 %
Seq. Revenue Change -8.82 %
Revenue In Millions $78,355.92
Gross Profit Margin 4.58 %
Gross Profit Margin Total Ranking # 3288
Gross Profit In Millions $3,588.34
Y / Y Gross Profit Change 17.27 %
Seq. Gross Profit Change 16.81 %


Commenting Second Quarter 2026 Gross Profit Margin
Cencora Inc achieved Gross Profit of $3,588 millions compare to Gross Loss of $3,072.07 millions booked in the previous quarter. Despite the sequential Revenue deterioration in Q2 of -8.82 % Cencora Inc managed to reduce Cost of Sales and increase Gross Profit by 16.81 % to $3,588 millions. Gross Profit Margin grew to 4.58 % a new company high.


Observing second quarter 2026 results within Pharmacy Services & Retail Drugstore industry 10 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 3288, from total ranking in the previous quarter at 3677.
Learn about Gross Margin
COR's Gross Profit Margin second quarter 2026 Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 11
Retail Sector # 175
Overall # 3263

Gross Profit Margin Statistics
High Average Low
4.58 % 3.57 % 3.14 %
(Mar 31 2026)  


COR Gross Income Trends • More of COR's Profitabilty Ratios • COR Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
COR's Cumulative Gross Profit Margin
Pharmacy Services & Retail Drugstore Industry Gross Profit Margin Trends and Statistics
Retail Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
COR's Gross Profit Margin Profitability versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for COR's Competitors
Gross Profit Margin Profit Margin for Cencora Inc 's Suppliers
Gross Profit Margin Profit Margin for COR's Customers

You may also want to know
COR's Annual Growth Rates COR's Profitability Ratios COR's Asset Turnover Ratio COR's Dividend Growth
COR's Roe COR's Valuation Ratios COR's Financial Strength Ratios COR's Gross Profit Growth
COR's Roa COR's Inventory Turnover Ratio COR's Growth Rates COR's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Pharmacy Services & Retail Drugstore Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue
Cosmos Health Inc   7.70 %$ 1.381  Millions$ 17.928  Millions
Cencora Inc   4.58 %$ 3,588.339  Millions$ 78,355.916  Millions
Mckesson Corporation  4.20 %$ 4,044.000  Millions$ 96,295.000  Millions
Cardinal Health Inc   4.10 %$ 2,498.000  Millions$ 60,940.000  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.